Pages that link to "Q27671695"
Jump to navigation
Jump to search
The following pages link to Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis (Q27671695):
Displaying 50 items.
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology (Q21129303) (← links)
- SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells (Q24338861) (← links)
- Targeting Cancer Metabolism - Revisiting the Warburg Effects (Q26738876) (← links)
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Metabolic, autophagic, and mitophagic activities in cancer initiation and progression (Q26745503) (← links)
- Pyruvate Kinase M2: A Potential Target for Regulating Inflammation (Q26752535) (← links)
- Dysregulated metabolism contributes to oncogenesis (Q26784630) (← links)
- Pyruvate kinase: Function, regulation and role in cancer (Q26798084) (← links)
- Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes (Q26829985) (← links)
- Is cancer a metabolic disease? (Q26852241) (← links)
- Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways (Q26861539) (← links)
- Pyruvate kinase M2 at a glance (Q27005722) (← links)
- Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma (Q27015699) (← links)
- Fueling immunity: insights into metabolism and lymphocyte function (Q27025284) (← links)
- M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation (Q27677066) (← links)
- Heterogeneity of glycolysis in cancers and therapeutic opportunities (Q27693375) (← links)
- Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer (Q28072669) (← links)
- ROS homeostasis and metabolism: a critical liaison for cancer therapy (Q28080316) (← links)
- A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect (Q28237387) (← links)
- Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability (Q28242891) (← links)
- Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression (Q28294651) (← links)
- The cellular and compartmental profile of mouse retinal glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and ~P transferring kinases (Q28385023) (← links)
- Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells (Q28542057) (← links)
- Structures of pyruvate kinases display evolutionarily divergent allosteric strategies (Q28646838) (← links)
- Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity (Q28655910) (← links)
- Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma (Q30928926) (← links)
- Glycolytic reliance promotes anabolism in photoreceptors (Q33879266) (← links)
- 18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma (Q33889303) (← links)
- In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers (Q33895166) (← links)
- Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis (Q34170794) (← links)
- Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy (Q34179999) (← links)
- Endothelial cell metabolism: parallels and divergences with cancer cell metabolism (Q34228247) (← links)
- Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells (Q34258961) (← links)
- Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization (Q34280065) (← links)
- Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis (Q34338923) (← links)
- PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. (Q34377342) (← links)
- Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways (Q34390494) (← links)
- Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question (Q34459681) (← links)
- PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2. (Q34498995) (← links)
- Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics (Q34757824) (← links)
- Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis (Q34777160) (← links)
- Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein. (Q34777828) (← links)
- Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation (Q34898927) (← links)
- Fluorescent probes of the apoptolidins and their utility in cellular localization studies (Q34944937) (← links)
- HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells (Q35127901) (← links)
- The Warburg effect: evolving interpretations of an established concept (Q35169587) (← links)
- Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations (Q35178420) (← links)
- L-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2 (Q35189922) (← links)
- Activators of PKM2 in cancer metabolism (Q35215989) (← links)
- A PKM2 signature in the failing heart. (Q35235782) (← links)